Bill
SB 1367
Overview: SB 1367 - Long-acting injectable or extended-release prescription drugs; correctional facilities.Status: Acts of Assembly Chapter text (CHAP0283)Introduced: February 18,
Overview: SB 1367 - Long-acting injectable or extended-release prescription drugs; correctional facilities.
Status: Acts of Assembly Chapter text (CHAP0283)
Introduced: February 18, 2025
Purpose and Intent: The bill aims to improve access to long-acting injectable or extended-release prescription drugs for individuals incarcerated in state correctional facilities.
Key Provisions:
- Requires the Department of Corrections to provide long-acting injectable or extended-release prescription drugs to inmates when clinically appropriate
- Authorizes the use of Medicaid funds to cover the costs of these medications for eligible inmates
- Directs the Department to establish policies and procedures for the administration and monitoring of these drugs
Affected Parties and Impacts:
- Incarcerated individuals who will have improved access to long-acting prescription medications, particularly for mental health and substance abuse treatment
- State correctional facilities that will be required to provide and manage these specialized drug therapies
- Medicaid program that will cover the costs of eligible inmates' long-acting prescription drugs
Procedural and Timeline Considerations:
The bill has been enacted and will take effect immediately. The Department of Corrections must develop the necessary policies and procedures within 6 months of the bill's effective date.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
